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ABSTRACT 
P-glycoprotein (P-gp), a member of the ABC-transporter superfamily, is a 
transmembrane protein that holds clinical importance due to its role in drug 
metabolism and multi-drug resistance (MDR) in cancer. Because 
crystallization attempts have failed at elucidating its 3D structure, recent 
research efforts have focused on constructing homology models of human     
P-gp. Prior to 2009, these homology models were primarily based upon 
bacterial transporters such as Sav1866, MalkK, and MsbA that represented the 
outward-facing conformation of P-gp. Following the release of an inward-
facing mouse P-gp-based homology model of human P-gp, however, 
simulations modeling the inward- to outward-facing conformational change of 
P-gp have since been made possible. In this study, a targeted molecular 
dynamic (TMD) simulation is performed in order to model the translocation 
mechanism of human P-gp. This simulation provides insight into the gating 
scheme of P-gp itself as well as other ABC-transporters such as the cystic 
fibrosis transmembrane conductance regulator (CFTR), a protein implicated 
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1. INTRODUCTION 
1.1 P-glycoprotein 
P-glycoprotein (P-gp), also known as multidrug resistance protein 1 (MDR1) or ATP-
binding cassette sub-family B member 1 (ABCB1), is a transmembrane protein that in 
humans is encoded by the ABCB1 gene [1]. Classified within ATP-binding cassette 
(ABC) superfamily, this protein is expressed in the apical membrane of many 
secretory cell types such as kidney, liver, intestine, adrenal gland, and the blood–brain 
barrier [2]. P-gp holds clinical importance due to its ability to bind to and export a 
wide variety of xenobiotic compounds, making it a significant factor for the 
absorption, distribution, metabolism and excretion of drugs [3]. This efflux 
mechanism of P-gp is particularly significant as it confers a multi-drug resistance 
(MDR) phenotype to cancer cells that have developed resistance to chemotherapy 
drugs [4]. For these reasons, P-gp has garnered strong research interest and has 
become the most extensively studied ABC-transporter.  
P-gp consists of 1276-1280 amino acids with a molecular weight of approximately 
170kDa. Like many other ABC-transporters, this protein contains transmembrane 
domains (TMDs) comprised of 
twelve highly hydrophobic          
α-helices (Figure 1). Located 
intracellularly are two nucleotide 
binding domains (NBDs) that act Figure 1. Proposed topology of  P-gp [5] 
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as ATPase, hydrolyzing ATP and thereby generating the energy required for P-gp to 
actively pump substrate through the TMDs and across the membrane [5].  
Due to the role that it plays in MDR of cancer cells as well as normal 
pharmacokinetics, P-gp has been identified as a key anti-target in modern drug 
discovery [6]. Preceding the ability to predict whether or not a lead compound will 
interact with P-gp, however, is an understanding of the mechanisms by which P-gp 
binds to and transports its many substrates. In accordance with the central dogma of 
molecular biology “Structure determines function”, the first step in elucidating these 
mechanisms is to determine the 3D structure of this protein. Human P-gp, like many 
other membrane proteins, is difficult to crystallize. Even when expressed at high 
levels, P-gp does not purify well as surrounding lipid molecules interfere with 
crystallography and nuclear magnetic resonance (NMR) spectroscopy [7]. As a result, 
high-quality 3D structures of P-gp do not yet exist. Researchers, therefore, have 
recently begun to pursue an indirect method of structure prediction called homology 
modeling.  
1.2. Homology modeling and existing P-gp models 
Homology modeling is the process by which a 3D model, or homology model, for a 
protein of unknown structure is constructed based upon sequence similarity to 
proteins of known structure (Figure 2) [8]. The first step of homology modeling is to 
identify the template protein by aligning the primary amino acid sequence of the 
target protein to a large database of related sequences all with known 3D structures. 
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This process, known as multiple sequence 
alignment, scores each sequence entry in 
the database on its similarity to the target 
sequence. The entry with the highest 
degree of homology serves as the template 
protein. In regions of high correlation 
between the target and template primary -
sequence, local structure of the target 
sequence can be deduced based on the 
known structure of the template sequence. In the second step, spatial constraints are 
applied to individual residues of the target sequence by quantifying these deductions. 
Finally, using modeling software, an atomic-resolution model of the target protein 
can be created using its primary amino acid sequence and the appropriate spatial 
constraints from the template protein. 
Development of human P-gp homology models has flourished recently following the 
emergence of several 3D structures of bacterial ABC-transporters such as Sav1866, 
MalK, and MsbA [9-12]. Staphylococcus aureus Sav1866-based homology models remain 
the most robust and complete structures of P-gp in the ATP-bound closed or 
“outward-facing” state. This is because i. all three MsbA crystal structures have been 
retracted due to data misinterpretation [13] and ii. MalK-based models require 
extrapolation of TMD structure as they only provide information on NBD 
conformation. Sequence identity between Sav1866 and P-gp differs markedly for each 
Figure 2. Overview of  homology modeling 
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domain, ranging between 12.9-15.8% in the TMDs to 44.6-48.4% in the NBDs. 
Sequence similarity between the two proteins, however, is much higher; 52.8-56% in 
the TMDs and 77.8-80.4% in the NBDs [10]. Such similarity in sequence confers a 
high degree of secondary structure conservation, making Sav1866 an ideal template 
for the outward-facing conformational state of human P-gp (outP-gp) as 
demonstrated in the model created by Callaghan et al (Figure 3b) [14]. 
Prior to 2009, homology models representing the inward-facing state of P-gp were 
limited by crude template proteins such as MsbA [12] or incomplete templates such 
as MalK [10]. In a seminal study by Aller et al, an X-ray structure of mouse P-gp with 
87% sequence identity to human P-gp was produced, thereby providing a far-superior 
template for the inward-facing conformational state of human P-gp (inP-gp) [15]. 
Several models of inP-gp based on this structure have since been presented [16, 17], 
including that of Tarcsay et al in 2011 (Figure 3a) [18].  
Considerable evidence exists suggesting that the P-gp translocation mechanism 
occurs through ATP-induced NBD dimerization, which results in conformational 
change between at least two distinguishable states. This has been inferred through 
experiments [19] and simulations on homologous ABC-transporters such as        
MalK [20]. Crystal structures of ABC-transporters in open [21], semi-open [22], and 
closed states [23] provide further support for this assumption. A recent study utilized 
FRET analysis to demonstrate that P-gp fluctuates between two major conformations 
during steady state  turnover [24]. Despite all these  findings,  there  is  still  very  little  
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Figure 3. Representations of  (a and b) the mouse P-gp-based homology model 
[18] and (c and d) the Sav1866-based homology model [14] of  human P-gp. 
These structures were used to define the inward- and outward-facing conforma-
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understanding of the precise mechanism that would result in multiple P-gp 
conformational states. One can immediately understand the value of a creating a 
molecular dynamics simulation modeling the translocation mechanism of                  
P-glycoprotein as it exists in membrane. 
Molecular dynamic simulations based upon structures deduced by homology 
modeling is a technique that has been used to model the conformational changes 
exhibited in a number of proteins including H+K+ ATPase proton pumps [25],        
G protein-coupled receptors (GPCRs) [26], and even ABC-transporters such as the 
bacterial vitamin B(12) transporter BtuCD [27]. To date however, no equivalent 
simulation has been reported for human P-gp despite the recent emergence of mouse 
P-gp-based inward-facing homology models that, in conjunction with existing 
outward-facing structures, would be make such a simulation possible. Therefore, the 
objective of this study is to design the first-ever targeted molecular dynamics 
simulation of the P-gp translocation mechanism using pre-defined homology models. 
1.3. Molecular dynamics 
Molecular dynamics simulations are computational-based processes by which a 
molecular model is animated at an atomic level over a brief timescale, such as pico- or 
nanoseconds, in order to represent the innate “jigglings and wigglings of atoms” [28]. 
Molecular dynamics simulations can be used to find a pathway between multiple 
conformational states of a protein such as P-gp. One specific method through which 
this is done is targeted molecular dynamics (TMD). In this approach, the protein is 
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guided from one conformation to another by means of an external steering forces, 
typically calculated as a function of the distance between the current and target 
positions of the atoms [29, 30].  
It is important to note that, due to computational limitations, the timescale of the 
TMD simulation reported in this study are not equivalent to that of actual molecular 
processes. Despite this, however, several recent studies have shown that dynamic 
simulations can still produce qualitatively accurate pathways for actual conformational 
change [25-27, 31-33].  
1.4. Relevance to CFTR and other ABC-transporters 
P-gp, as mentioned before, is a member of the ATP-binding cassette (ABC) 
transporter superfamily. Due to their vital role in transport of a wide variety of 
substrates including drugs, metabolites, and lipids, ABC-transporters, when mutated, 
can result in several serious diseases. 
Cystic fibrosis (CF) is a recessive genetic disorder regarded as the most lethal genetic 
disease among Caucasian populations. CF results from mutations in the cystic fibrosis 
transmembrane conductance regulator (CFTR) gene responsible for encoding the 
CFTR protein, a member of the ABC-transporter superfamily [34]. Although over 
1,500 such mutations have been described, the structural consequences of these 
mutations are difficult to understand due to lack of success in crystallizing            
CFTR [35, 36]. Recent efforts have crystallized certain domains of CFTR, however 
the overall 3D structure still remains largely undefined [37]. This challenge has 
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stimulated a flourish of homology modeling studies beginning in 2008 when Riordan 
and colleagues created the first-ever CFTR homology model [38]. 
Currently, there exist three notable homology models for CFTR based upon the 
crystal structure of Sav1866 [39-41]. These models putatively represent the outward-
facing or open conformation of CFTR and, as a result, do not allow for deduction of 
the gating scheme between open and closed conformational states. By creating a 
CFTR homology model based upon a protein representing the inward-facing or 
closed conformation such as mouse P-gp, molecular dynamics simulations can be 
performed in order to elucidate CFTR’s gating scheme.  
The simulation reported in this study can yield a realistic picture of the structural 
changes accompanying the gating cycle of both P-gp itself and that of ABC-
transporters that use the mouse P-gp structure as a template for homology modeling. 
Given the structural similarities between P-gp and CFTR, such as the fact that they 
both have twelve transmembrane helices and highly conserved NBDs, some 
assumptions of the CFTR gating scheme can be made based upon what is observed 
during the P-gp simulation. For instance, if certain helices rotate or translate from a 
buried position towards a pore-facing conformation over the course of the simulation, 
these helices may play an important role in the CFTR gating scheme, as they are most 
likely important for defining the ion channel. Deductions such as this can facilitate 
the creation of a more robust simulation of the CFTR gating scheme. 
	   XIV	  
Development of a simulation representing CFTR’s gating scheme has profound 
pharmaceutical and clinical significance. As such a simulation would allow for 
determination of specific residues critical to ion conduction function, it would enable 
identification of potential drug binding sites required to lock CFTR into an open 
conformation. This would increase Cl- secretion, improve osmotic flow out of 
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2. MATERIALS 
Visual Molecular Dynamics (VMD) version 1.8.7 was used for all molecular 
visualization and analysis purposes in this study [42]. Various plugins featured in this 
application were used to construct the membranous environment. This software was 
run on a 2.4 GHz dual-core MacBook using Mac OS X 10.7.3. 
All molecular dynamics simulations were completed using NAMD version 2.7 [43]. 
Simulation runs utilized the high performance computing (HPC) facility overseen by 
the Georgia Tech Partnership for an Advanced Computing Environment (PACE). 
Although the quantity of processors and runtime varied for different simulation runs, 
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3. METHODS 
A TMD simulation was performed to model the translocation mechanism of human 
P-gp, or the inward- to outward-facing (IàO) transition. Before this simulation could 
be completed, however, a membranous environment was first constructed in order to 
emulate the conditions of P-gp in situ (Figure 4). 
3.1. Defining conformational states of P-gp 
The first and most crucial step in simulating human P-gp was to identify the 
conformational states of the protein. After extensive literature review, the outward-
facing state was chosen to be defined by the Sav1866-based homology model set 
forth by Callaghan et al in 2007 [14]. The mouse P-gp-based homology model 
published by Tarcsay et al in 2011 was chosen to represent the inward-facing state of 
human P-gp [18]. The pdb coordinates for these two models were graciously 
provided by the respective research groups upon request. 
As the homology models, upon receipt, had different orientations in space, both were 
aligned to their respective template proteins as they exist in membrane. Information 
on the spatial arrangements of these template proteins was provided by the 
Orientations of Proteins in Membranes (OPM) database, which positions proteins in 
a lipid bilayer of adjustable thickness by minimizing the transfer energy of the protein 
from water to the membrane [44]. The homology models were aligned to their 
respective OPM template proteins along the Z-axis through a rigid body 
transformation by RMSD minimization of corresponding α-carbons (Figure 4a).  
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Using the Automatic PSF Builder extension of VMD, a Protein Structure File (PSF) 
was created for the two P-gp homology models. The topology file used for the PSF 
generation was the default CHARMM27 force field [45-47].  
3.2. Constructing a membranous environment 
A 140x140	   Å palmitoyloleoylphosphatidylcholine (POPC) lipid bilayer patch 
composed of 546 POPC molecules was created using the Membrane Builder 
extension of VMD. Following manual alignment of the membrane patch to the     
inP-gp structure, all lipids within a cut-off distance of 1.2 Å from the protein were 
removed as suggested (Figure 4b) [48]. Water molecules generated along with the 
membrane and located within 3.0 Å of the protein were also removed. 
While holding the protein fixed, a brief 5 ps steepest decent minimization was 
completed in order to relax any steric conflicts generated during construction of the 
system. For this and all subsequent minimizations and equilibrations, periodic 
boundary conditions were used with a 140x140x180 Å simulation cell. Appropriate 
disorder of a fluid-like bilayer was introduced through a 0.5 ns Langevin dynamics 
simulation performed in the NVT ensemble at 310 K (Figure 4c). Throughout this 
simulation, protein atoms were held fixed as well. The phosphate head groups of all 
lipids were restrained to the bilayer plane by imposing harmonic restraints on the Z 
components of coordinates. This capacitated mobility of the lipid molecules about 
the XY-plane, allowing for improved fitting of the membrane around the protein. 
 
	   XVIII	  
 
	   XIX	  
Following an initial minimization and equilibration, the system was solvated using 
VMD’s Solvate extension (Figure 4d). A solvent box composed of TIP3 water 
molecules was created with the same dimensions as the simulation cell         
(140x140x180 Å) and all water molecules within 1.5 Å of solute were removed [49]. 
Using Autoionize extension of VMD, K+ and Cl- ions were positioned randomly 
throughout the solvent box to a total concentration of 200 mM. Two iterations of      
5 ps steepest decent minimization were performed on the solvated and ionized 
system, first with the protein constrained and second with harmonic restraining 
forces applied to the Cα backbone. The system was then gradually heated to 310 K 
over 20 ps with Cα restraints. 
The final inP-gp system included 354,713 atoms, 1,173 residues, 463 POPC lipids, 
165 K+ ions, 177 Cl- ions, and 91,283 water molecules. This was used as the starting 
structure in the TMD simulation. The Sav1866-based outP-gp homology model 
aligned using OPM data was used as the target structure. 
3.3. Targeted molecular dynamics 
VMD’s targeted molecular dynamics were used to guide the IàO transition of P-gp. 






[RMSD(t)− RMSD*(t)]2 	  
where RMSD(t) is the instantaneous best-fit root mean square distance of the current 
coordinates to the target coordinates, RMSD*(t) is the preset RMSD (or the RMSD 
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between the initial and target structures) for the current timestep, k is the elastic 
constant for TMD forces, and N is the number of targeted atoms [50]. RMSD*(t) was 
initially set to 12.647 Å and decreased to 0 Å monotonically. An external spring force 
(k) of 5,865 kcal/mol/Å2 was applied to the 1,173 Cα atoms (N) of P-gp as suggested 
in TMD simulations of similar proteins [27]. The simulation was completed in 0.5 ns 
at 310K and constant NVT conditions using Langevin dynamics, periodic boundary 
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4. RESULTS 
During the TMD simulation, coordinates were saved every 500 steps, or every 500 fs, 
for analysis. Progression through the IàO transition can be best observed by 
overlaying the instantaneous structure onto the target outP-gp structure and 
comparing the stuctures at various time points along the trajectory (Figure 5). 
Although it is clear that the final structure of P-gp does not conform perfectly to the 
target structure, the steering force and duration of the simulation sufficiently reduce 
the overall RMSD from 12.647 Å to 7.760 Å throughout the simulation.  
Perhaps the most interesting and significant observation from the simulation is that 
the major conformational changes in the NBDs appear to precede the shifts in the 
TMDs. After 200 ps, the NBDs have approached each other and begin to dimerize. 
Up through this point, little structural change is observed in the TMDs aside from 
the expected decrease in the angle between the two bundles of six helices              
(TMs 1-3,6,10,11 and TMs 4,5,7-9,12) that, together, constitute the two halves of P-
gp. Over the next 300 ps, however, the transmembrane (TM) helices undergo 
significant change, resulting in the ‘scissoring’ motion observed from the side 
perspective. This sequence of events correlates well with the hypothesis that binding 
of ATP, stimulated by a bound substrate, causes a dimerization in the NBDs that 
then drives structural changes in the TMDs to create an outward facing conformation 
similar to that of Sav1866 [15]. 
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0 ps
Figure 5. Progression of  the I->O transition of  P-gp throughout TMD simulation. For 
each time step, the structure is viewed from both the front (left) and side (right). A 
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Although TMD simulations provide an excellent depiction of large-scale 
conformational changes, typical cartoon representations of the molecular structure 
can mask changes in the protein’s pore. For this reason, the program HOLE was 
used to generate the radius profile of the translocation pathway of P-gp at different 
timesteps along the simulation (Figure 6) [51]. This program works by iteratively 
moving a point along the plane normal to the pore vector and growing it so as to find 
the largest sphere that can be accommodated without overlapping with the van der 
Walls radii of adjacent protein atoms. Once the largest sphere is determined, the 
point undergoes a small displacement along the direction of the pore vector a repeats 
the process. What results is a detailed ‘casting’ of a protein’s pore. 
At the 0 ps timestep, HOLE analysis shows P-gp to have a very large internal cavity 
open to both the cytoplasm and the inner lipid leaflet. The radius at the widest 
portion of this cavity occurs between -70 < Z < -45 Å, a region defined by 
intracellular loops (ICLs) that couple the TMDs and NBDs. The maximal radius of 
this region, determined by plotting the radius profile at various timesteps (Figure 7), 
is nearly 12 Å. This large cavity continues up through the lipid bilayer where drug-
binding sites have been shown to reside. The volume of the cavity within the cell 
membrane is substantial and appears to be able to accommodate at least two 
compounds simultaneously as previously suggested [52]. Another characteristic of 
this initial inward-facing conformational state is that the pore radius nearly converges 
to zero at the extracellular face of the membrane domain around Z = 30 Å. This  
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0 ps
Figure 6. Representations of  the P-gp translocation pathway throughout TMD simula-
tion as determined by HOLE. For each time step, the structure is viewed from both the 
front (left) and side (right). The pathway is colored such that parts inaccessible to water 
(pore radius < 1.15 Å) are red, water accessible parts (1.15 Å > pore radius < 2.30 Å) are 
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observation supports the idea that the inward-facing structure does not allow 
substrate access from the outer membrane leaflet nor the extracellular space [15].      
Through the IàO transition of P-gp, the large cytoplasmic cavity is slowly reduced in 
radius as the NBDs dimerize until eventually, at 500 ps, the pore becomes occluded 
at this side (Z = -83 Å). Most interesting is the fact that, as the P-gp pore closes on 
the cytoplasmic side, it simultaneously dilates at the extracellular domain, particularly 
within the region Z > 5 Å. At no point, however, is a transient structure observed 
with both ends open. In other words, at any point along the IàO transition, P-gp is 
either occluded or very much constricted (radius < 2.30 Å) at one or more locations 
Figure 7. Variation of  the translocation pore radius throughout the I->O transition. 
Z-coordinates are used as they correspond to the axis to which P-gp was aligned.
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along the translocation pathway. This observation supports the widely recognized 
theory that P-gp is a unidirectional efflux transporter that operates using an 
“alternating access” mechanism. Likening this conformational change to the motion 
of scissors, the joint or pivot point of P-gp appears to be the region -7 Å < Z < 4 Å 
where pore radius can be seen to experience little change during the simulation.  
In order to better understand the conformational changes of the individual TM 
helices of P-gp, RMSD trajectories were calculated on α-carbons of the residues 
defining each TM helix (Figure 8). This data was provided by the OPM database 
entry for the mouse P-gp structure (Figure 8a) [44]. RMSD trajectories were then 
plotted for all twelve TM helices of TMD1 and TMD2 over the duration of the TMD 
simulation. From these plots, it is clear that not all helices undergo the same 
conformational changes (Figure 8b and 8c). The most dynamic helices in TMD1 are 
TM1 and TM2. For TMD2, helices TM7, TM8, and TM11 appear to undergo the 
most significant change. As would be expected, all of these helices are located on 
external surface of P-gp rather than the internal, pore-facing side. Conversely, TM6 
and TM12 are pore-aligning helices and are relatively static. Due to their location, 
these two helices are in contact with the substrate throughout the translocation 
mechanism and, thus, are vital to the protein:substrate interface. TM6 and TM12 are 
essential to CFTR channel activity, suggesting that they are pore aligning in the CFTR 
structure as well. This provides evidence to our initial claim that the TMD simulation 
performed here on P-gp may lend information on the gating cycles of other       
ABC-transporters. 







Figure 8. Residues defining the P-gp TMs were identified using OPM data and 
are depicted in green (a). RMSD values for both TMD1 (b) and TMD2 (c) were 
determined throughout the TMD simulation by calculating the instantaneous 
RMS distance between a TM’s ! carbons and their corresponding atoms in the 
target structure. 
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5. CONCLUSION 
In this study, the P-glycoprotein translocation mechanism has been simulated using 
targeted molecular dynamics. Results from this molecular dynamics model support 
several previously reported claims regarding the P-gp mechanism. The simulation 
demonstrates that NBD dimerization induces significant conformational changes in 
the TMD that result in the outward-facing state. Pore analysis agrees well with the 
hypothesis that P-gp is a unidirectional efflux transporter operating though an 
“alternating access” mechanism. This was achieved by showing that P-gp, at any 
point along its IàO transition, is either occluded or very much constricted at one or 
more locations in the translocation pathway thereby preventing bidirectional 
transport. In addition to providing insight into the P-gp mechanism itself, deductions 
can be made on the gating schemes of other ABC-transporters, such as CFTR, due to 
homologous structural characteristics and the conserved sequence similarity observed 
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